Gonadal function and fertility in males survivors treated for Hodgkin's disease in Iran

Saudi Medical Journal

Volumn 28, Issue 11, 2007, Pages 1690-1693

  Rafsanjani, Khadijeh A ^a   Faranoush, Mohammad ^b   Hedayatiasl, Amir A ^a   Vossough, Parvaneh ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FOLLITROPIN; LOMUSTINE; LUTEINIZING HORMONE; METHOTREXATE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; TESTOSTERONE; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; ARTICLE; AZOOSPERMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVOR; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL PROTOCOL; DISEASE SEVERITY; GONAD FUNCTION; HODGKIN DISEASE; HUMAN; IRAN; MALE; MALE FERTILITY; MULTIPLE CYCLE TREATMENT; OLIGOSPERMIA; SEMEN ANALYSIS; SIDE EFFECT; SPERMATOZOON COUNT; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AZOOSPERMIA; FOLLICLE STIMULATING HORMONE; HODGKIN DISEASE; HUMANS; IRAN; LUTEINIZING HORMONE; MALE; OLIGOSPERMIA; PUBERTY; SPERM COUNT; SURVIVORS; TESTOSTERONE;

EID: 36949025506     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hobbie WL, Ginseberg JP, Ogle SK, Carlson CA, Medows AT. Fertility in males treated for Hodgkins disease with COPP/ABV hybrid. Pediatr Blood Cancer 2005; 44: 193-196.
2. Young RC, Bookman MA, Longo DL. Late complications of Hodgkin's disease management. J Natl Cancer Inst Monogr 1990; 10: 55-60.
3. van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Bel-Dusebout AW, van Kerkhoff, et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 1994; 12: 312-325.
4. Ortin TT, Shostak CA, Donaldson SS. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: The Stanford experience. Int J Radiat Oncol Biol Phys 1990; 19: 873-880.
5. Sklar SM, Tsatsoulis A, Whitehead E, Read G. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol 1989; 120: 161-165.
6. Shalet SM, Tsatsoulis A, Whitehead E, Read G. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol 1989; 120: 161-165.
7. Derek R, Jenkin T, Berry MP. Hodgkin's disease in children. Semin Oncol 1980; 7: 202-211.
8. Donaldson SS, Glatstein E, Rosenberg SA, Kaplan HS. Pediatric hodgkin's disease. II. Results of theraphy. Cancer 1976; 37: 2436-2447.
9. Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. Gonadal toxicity after combination chemotheraphy for Hodgkin's disease. Comparative results of MOPP vs. ABVD. Eur J Cancer Clin Oncol 1985; 21: 601-605.
10. Mackie EJ, Radford M, Shalet SM. Gonadal function following chemotheraphy for childhood Hodgkin's disease. Med Pediatr Oncol 1996; 27: 74-78.
11. da Cunha MF, Meistrich ML, Fuller LM, Cundiff JH, Hagenmeister FB, Velasquez WS, et al. Recovery of spermatogenesis after treatment for Hodgkin's disease: Limiting dose of MOPP chemotheraphy. J Clin Oncol 1984; 2: 571-577.
12. Kreuser ED, Xiros N, Hetzel WD, Heimpel H. Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease. J Cancer Res Clin Oncol 1987; 113: 260-266
13. Green DM, Brecher ML, Lindsay AN, Yakar D, Voorhes ML, MacGillivray MH, et al. Gonadal function in pediatric patients following treatment for Hodgkin's disease. Med Pediatr Oncol 1981; 9: 235-244.
14. Ben Arush MW, Solt I, Lightman A, Linn S, Kuten A. Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma. Pediatr Hematol Oncol 2000; 17: 239-245.
15. Morgenfeld MC, Pavlovsky A, Suarez A, Somoza N, Pavlovsky S, Palau M, et al. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients. Cancer 1975; 36: 1241-1249.
16. Hassel JU, Bramswig JH, Schlegel W, Schellog G. Testicular function after OPA/COMP chemotherapy without procarbazine in boys with Hodgkin's. Results in 25 patients of the DAL-HD-85 study. Klin Pediatr 1991; 268-272. German.
17. Aubier F, Flamant F, Brauner R, Caillaud JM, Chaussain JM, Lemerle J. Male gonadal function after chemotherapy for solid tumors in childhood. J Clin Oncol 1989; 7: 304-309.
18. Pennisi AJ, Grushkin CM, Lieberman E. Gonadal function in children with nephrosis treated with cyclophosphamide. Am J Dis Child 1975; 129: 315-318.
19. Dhabhar BN, Malhotra H, Joseph R, Garde S, Bhasin S, Sheth A, et al. Gonadal function in prepubertal boys following treatment for Hodgkin's disease. Am J Pediatr Hematol Oncol 1993; 15: 306-310.
20. Zirkin BR. Spermatogenesis: Its regulation by testoterone and FSH. Semin Cell Dev Biol 1998; 9: 417-421.
21. Matsumoto AM, Paulsen CA, Bremner WJ. Stimulation of sperm production by human luteinizing hormone in gonadotropin-suppressed normal men. J Clin Endocrinol Metab 1984; 59: 882-887.
22. Harrison RG. Effect of temperature on the mammalian testis. In: Hamilton DW, Greep RW, editors. Handbook of Physiology, Section 7, Endocrinology. Male Reproductive System. Vol. 5. Washington (DC): American Physiological Society; 1975. p. A219-A223.
23. Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS. Prognostic Factors for Children With Hodgkin's Disease Treated With Combined-Modality Therapy. J Clin Oncol 2003; 21: 2026-2033.
24. Donaldson SS. A Discourse: The 2002 Wataru W. Sutow lecture. Hodgkin's disease in children - perspective and progress. Med Pediatr Oncol 2003; 40: 73-81.
25. World Health Organization. WHO Laboratory manual for the examinations. 3rd ed. New York (NY): Cambridge University Press; 1992.
26. Chan PTK, Palermo GD, Veeck LL, Rosenwaks Z, Schlegel PN. Testicular sperm extraction combined with intracytoplasmic sperm injection in the treatment of men with persistent azoospermia post-chemotherapy. Cancer 2001; 92: 1632-1637.